Our Authors
Dean Radin, PhD
Troy Rohn, PhD
J.L.Mee
Peter Seidler
Dean Radin, PhD is Chief Scientist at the Institute of Noetic Science (IONS), Associated Distinguished Professor at the California Institute of Integral Studies, and co-founder and chairman of the genetic neuroengineering company, Cognigenics, Inc. Before joining the IONS research staff in 2001, he worked at AT&T Bell Labs, Princeton University, University of Edinburgh, and SRI International.
Radin is a co-inventor on 12 patents, and author or coauthor of over 350 scientific, technical, and popular articles, book chapters, and books, including The Conscious Universe, Entangled Minds,; Supernormal, the best selling Real Magic, and The Science of Magic. In 2017 he was named one of the 100 most inspiring people in the world by the German magazine, OOOM, as of 2025 his filmography on IMDB listed 40+ film, television programs, and documentaries.
His 180+ scientific articles can be found in peer-reviewed journals ranging from Foundations of Physics to PLOS One, PNAS Nexus, Nature Translational Psychiatry, Frontiers in Human Neuroscience, Psychological Bulletin, Brain and Cognition, and Psychology of Consciousness.
J.L. Mee is a leading innovator in the emerging field of human cognitive enhancement and holds multiple patents pending on genetic methods for enhancing cognition. He is the founder of Cognigenics, Inc., a pioneering neurotech company developing precision gene therapies to improve mental health and cognitive performance.
Together with co-inventors Dr. Dean Radin and Dr. James Fallon, Mr. Mee formulated the world's first cognitive neuroengineering systems architecture—a multidisciplinary framework applying cognitive genetics to expand awareness, increase mental clarity, and optimize neural function.
Earlier in his career, Mr. Mee led major R&D initiatives in the computer industry, directing programs involving thousands of engineers which produced fundamental innovations in large-scale systems hardware design. He brings this deep engineering rigor and the discipline of building complex, commercially successful systems to the evolution of human consciousness.
Troy Rohn, PhD is a Neuroscientist, Professor, and Author with three decades of experience in Neuroscience. His work includes neurobiology, Alzheimer’s, and a special interest in anxiety.
In his new book ‘Brain Medicine,’ he delves into his personal journey with anxiety and discusses the new revolutionary RNAi gene therapies developed for anxiety & other neuropsychiatric disorders. Developed by Cognigenics, the biotech company co-founded by Dr. Rohn, these therapies deliver unprecedented precision intranasally, without the common undesirable side effects of traditional drug therapies.
Dr. Rohn's work is compelling, with a rare and unique authenticity as he hasn’t just studied anxiety but has lived with it. To learn more visit Cognigenics website or Dr Rohn’s, healingthroughgenes .com
Peter Seidler is Cognigenics' Chief Operating Officer with 30+ years building breakthrough technology companies—from pioneering digital transformation in the early web era (taking one company public with operations across 14 offices globally) to consumer genetics diagnostics and neurological treatment clinics in Asia. Throughout his career, Seidler has created and built organizations that connect advanced scientific research with practical solutions to benefit the human experience.
A Harvard Business School graduate and former board member of major cultural institutions supporting visual arts and technology-focused artists, Peter brings a unique blend of operational rigor, cultural innovation, and systems thinking honed through years of meditation practice with Dzogchen masters in Tibet and Nepal. At Cognigenics, he's architecting the "Connectome"—the integrated infrastructure, regulatory strategy, and knowledge systems that will enable the company to scale its intranasal mRNA and siRNA therapeutics from IND submissions through commercialization.